Skip to main content

Table 2 Common clinical data elements

From: The RENAPE observational registry: rationale and framework of the rare peritoneal tumors French patient registry

Patient information

 

 Contact details

 

 Current or past professional activity

 

 Medical contact details

 

 Personal and family relevant medical history

 

Preoperative work

 

 Occupational/environmental exposure (asbestos, erionite, mica, etc.)

 

 Etiology

 

 Diagnosis date and circumstances

 

 Height

 

 Weight

 

 Imaging: MRI, CT-TDM, PET scan

 

 Biology: tumor markers, creatinine

 

 Neoadjuvant treatments:

 

  PIPAC

 

  Chemotherapy: dates, no. cycles, regimen

 

  Radiotherapy: dates, dose (Gy)

 

  Surgery: date, intervention (laparotomy, CRS)

 

Peroperative data

 

 Date of surgery

 

 ASA score

 

 ECOG Performance Status

 

 Peritoneal Cancer Index (PCI)

 

 CCR score

 

 Spleen removal surgery

 

 Time of surgery

 

 Intraperitoneal chemotherapy:

 

  HIPEC modalities

 

  Chemotherapeutic agent(s) used

 

  Dose

 

 Type of postoperative analgesia

 

90-day postoperative follow-up

 

 Major complications (based on CTCAE v4.0):

 

  Hematologic

 

  Cardiovascular

 

  Inflammatory fever

 

  Surgical

 

  Hemorrhage, hemoperitoneum, intra-abdominal hematomas

 

  Gastrointestinal

 

  Pulmonary

 

  Nephrologic

 

  Urologic

 

 Re-intervention (surgery)

 

 Image-guided drainage

 

 Endoscopic treatment

 

 Radiologic treatment

 

 Duration of ICU

 

 Hospital stay

 

 90-day vital status

 
  1. Abbreviations: CCR completeness of cytoreduction, CRS cytoreductive surgery, CTCAE Common Terminology Criteria for Adverse Events, HIPEC Hyperthermic Intraperitoneal Chemotherapy, ICU Intensive Care Unit, PCI Peritoneal Cancer Index, PIPAC pressurized intraperitoneal aerosol chemotherapy